187 related articles for article (PubMed ID: 31255252)
1. [Cancers in systemic sclerosis : risk factors, impact on survival and literature review].
Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
[TBL] [Abstract][Full Text] [Related]
2. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis. A report of two cases.
Kuwana M; Fujii T; Mimori T; Kaburaki J
Arthritis Rheum; 1996 Apr; 39(4):686-91. PubMed ID: 8630122
[TBL] [Abstract][Full Text] [Related]
4. [Systemic scleroderma and cancer. Search for predictive factors of cancer in 123 patients with scleroderma].
Kyndt X; Hebbar M; Queyrel V; Hachulla E; Hatron PY; Devulder B
Rev Med Interne; 1997 Jul; 18(7):528-32. PubMed ID: 9255370
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for malignancy in systemic sclerosis patients.
Kaşifoğlu T; Yaşar Bilge Ş; Yıldız F; Özen G; Pehlivan Y; Yılmaz N; Tarhan F; Yılmaz S; Küçük A; Emmungil H; Koca SS; Çınar M; Direskeneli H; Erken E; Can G; Özmen M; Gönüllü E; Kisacik B; Aksu K; Karadağ O; Kasifoglu N; Arslantas D; Sahin F; Keser G; Yavuz S; Birlik M; Onat AM
Clin Rheumatol; 2016 Jun; 35(6):1529-33. PubMed ID: 27118199
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature.
Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Vacchi C; Spagnolo P; Cerri S; Luppi F; Richeldi L; Ferri C
Autoimmun Rev; 2013 Jan; 12(3):374-9. PubMed ID: 22743031
[TBL] [Abstract][Full Text] [Related]
7. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
8. Cancer in systemic sclerosis.
Abu-Shakra M; Guillemin F; Lee P
Arthritis Rheum; 1993 Apr; 36(4):460-4. PubMed ID: 8457221
[TBL] [Abstract][Full Text] [Related]
9. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
[TBL] [Abstract][Full Text] [Related]
10. Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis.
Hashimoto A; Arinuma Y; Nagai T; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
Intern Med; 2012; 51(13):1683-8. PubMed ID: 22790126
[TBL] [Abstract][Full Text] [Related]
11. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic systemic sclerosis: About 3 cases and review of literature.
Monfort JB; Lazareth I; Priollet P
J Mal Vasc; 2016 Dec; 41(6):365-370. PubMed ID: 27751625
[TBL] [Abstract][Full Text] [Related]
13. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
[TBL] [Abstract][Full Text] [Related]
14. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
15. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis and malignancy.
Sargin G; Senturk T; Cildag S
Int J Rheum Dis; 2018 May; 21(5):1093-1097. PubMed ID: 29673080
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study.
Lopez L; Barnetche T; Galli G; Seneschal J; Blanchard E; Shipley E; Pellegrin JL; Lazaro E; Constans J; Duffau P; Schaeverbeke T; Richez C; Kostine M; Truchetet ME
Joint Bone Spine; 2023 May; 90(3):105555. PubMed ID: 36842760
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases.
Kameda H; Kuwana M; Hama N; Kaburaki J; Homma M
J Rheumatol; 1997 Feb; 24(2):400-3. PubMed ID: 9035005
[TBL] [Abstract][Full Text] [Related]
19. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis.
Antonelli A; Ferri C; Ferrari SM; Di Domenicantonio A; Giuggioli D; Galleri D; Miccoli P; Fallahi P
Rheumatology (Oxford); 2016 Mar; 55(3):480-4. PubMed ID: 26424836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]